Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Joshua Schwochert is active.

Publication


Featured researches published by Joshua Schwochert.


Journal of Medicinal Chemistry | 2015

Probing the Physicochemical Boundaries of Cell Permeability and Oral Bioavailability in Lipophilic Macrocycles Inspired by Natural Products

Andrew T. Bockus; Katrina W. Lexa; Cameron R. Pye; Amit S. Kalgutkar; Jarret W. Gardner; Kathryn C. R. Hund; William M. Hewitt; Joshua Schwochert; Emerson Glassey; David A. Price; Alan M. Mathiowetz; Spiros Liras; Matthew P. Jacobson; R. Scott Lokey

Cyclic peptide natural products contain a variety of conserved, nonproteinogenic structural elements such as d-amino acids and amide N-methylation. In addition, many cyclic peptides incorporate γ-amino acids and other elements derived from polyketide synthases. We hypothesized that the position and orientation of these extended backbone elements impact the ADME properties of these hybrid molecules, especially their ability to cross cell membranes and avoid metabolic degradation. Here we report the synthesis of cyclic hexapeptide diastereomers containing γ-amino acids (e.g., statines) and systematically investigate their structure-permeability relationships. These compounds were much more water-soluble and, in many cases, were both more membrane permeable and more stable to liver microsomes than a similar non-statine-containing derivative. Permeability correlated well with the extent of intramolecular hydrogen bonding observed in the solution structures determined in the low-dielectric solvent CDCl3, and one compound showed an oral bioavailability of 21% in rat. Thus, the incorporation of γ-amino acids offers a route to increase backbone diversity and improve ADME properties in cyclic peptide scaffolds.


Journal of Medicinal Chemistry | 2015

Going Out on a Limb: Delineating The Effects of β-Branching, N-Methylation, and Side Chain Size on the Passive Permeability, Solubility, and Flexibility of Sanguinamide A Analogues.

Andrew T. Bockus; Joshua Schwochert; Cameron R. Pye; Chad E. Townsend; Vong Sok; Maria A. Bednarek; R. Scott Lokey

It is well established that intramolecular hydrogen bonding and N-methylation play important roles in the passive permeability of cyclic peptides, but other structural features have been explored less intensively. Recent studies on the oral bioavailability of the cyclic heptapeptide sanguinamide A have raised the question of whether steric occlusion of polar groups via β-branching is an effective, yet untapped, tool in cyclic peptide permeability optimization. We report the structures of 17 sanguinamide A analogues designed to test the relative contributions of β-branching, N-methylation, and side chain size to passive membrane permeability and aqueous solubility. We demonstrate that β-branching has little effect on permeability compared to the effects of aliphatic carbon count and N-methylation of exposed NH groups. We highlight a new N-methylated analogue of sanguinamide A with a Leu substitution at position 2 that exhibits solvent-dependent flexibility and improved permeability over that of the natural product.


Organic Letters | 2015

Peptide to Peptoid Substitutions Increase Cell Permeability in Cyclic Hexapeptides

Joshua Schwochert; Rushia Turner; Melissa Thang; Ray F. Berkeley; Alexandra R. Ponkey; Kelsie M. Rodriguez; Siegfried S. F. Leung; Bhagyashree Khunte; Gilles H. Goetz; Chris Limberakis; Amit S. Kalgutkar; Heather Eng; Michael J. Shapiro; Alan M. Mathiowetz; David A. Price; Spiros Liras; Matthew P. Jacobson; R. Scott Lokey

The effect of peptide-to-peptoid substitutions on the passive membrane permeability of an N-methylated cyclic hexapeptide is examined. In general, substitutions maintained permeability but increased conformational heterogeneity. Diversification with nonproteinogenic side chains increased permeability up to 3-fold. Additionally, the conformational impact of peptoid substitutions within a β-turn are explored. Based on these results, the strategic incorporation of peptoid residues into cyclic peptides can maintain or improve cell permeability, while increasing access to diverse side-chain functionality.


Journal of Natural Products | 2015

Biosynthetic Products from a Nearshore-Derived Gram-Negative Bacterium Enable Reassessment of the Kailuin Depsipeptides

Christine M. Theodore; Nicholas Lorig-Roach; Patrick C. Still; Tyler A. Johnson; Marija Draskovic; Joshua Schwochert; Cassandra N. Naphen; Mitchell S. Crews; Simone A. Barker; Frederick A. Valeriote; R. Scott Lokey; Phillip Crews

Sampling of California nearshore sediments resulted in the isolation of a Gram-negative bacterium, Photobacterium halotolerans, capable of producing unusual biosynthetic products. Liquid culture in artificial seawater-based media provided cyclic depsipeptides including four known compounds, kailuins B-E (2-5), and two new analogues, kailuins G and H (7 and 8). The structures of the new and known compounds were confirmed through extensive spectroscopic and Marfeys analyses. During the course of these studies, a correction was made to the previously reported double-bond geometry of kailuin D (4). Additionally, through the application of a combination of derivatization with Moshers reagent and extensive (13)C NMR shift analysis, the previously unassigned chiral center at position C-3 of the β-acyloxy group of all compounds was determined. To evaluate bioactivity and structure-activity relationships, the kailuin core (13) and kailuin lactam (14) were prepared by chiral synthesis using an Fmoc solid-phase peptide strategy followed by solution-phase cyclization. All isolated compounds and synthetic cores were assayed for solid tumor cell cytotoxicity and showed only minimal activity, contrary to other published reports. Additional phenotypic screenings were done on 4 and 5, with little evidence of activity.


Organic Letters | 2014

Revisiting N-to-O Acyl Shift for Synthesis of Natural Product-like Cyclic Depsipeptides

Joshua Schwochert; Cameron R. Pye; Christopher Ahlbach; Yashar Abdollahian; Kathleen A. Farley; Bhagyashree Khunte; Chris Limberakis; Amit S. Kalgutkar; Heather Eng; Michael J. Shapiro; Alan M. Mathiowetz; David A. Price; Spiros Liras; R. Scott Lokey

Despite the prevalence of head-to-side chain threonine linkages in natural products, their incorporation has been underexplored in synthetic cyclic peptides. Herein we investigate a cyclic peptide scaffold able to undergo an N-O acyl rearrangement. Upon acylation of the amine with diverse carboxylic acids, the resulting cyclic depsipeptides displayed favorable cellular permeability and a conformation similar to the parent peptide. The rearrangement was found to be scaffold and conformation dependent as evidenced by molecular dynamics experiments.


Antimicrobial Agents and Chemotherapy | 2017

Synthetic Cyclic Peptomers as Type III Secretion System Inhibitors

Hanh Lam; Joshua Schwochert; Yongtong Lao; Tannia Lau; Cameron Lloyd; Justin Luu; Olivia Kooner; Jessica Morgan; Scott Lokey; Victoria Auerbuch

ABSTRACT Antibiotic-resistant bacteria are an emerging threat to global public health. New classes of antibiotics and tools for antimicrobial discovery are urgently needed. Type III secretion systems (T3SS), which are required by dozens of Gram-negative bacteria for virulence but largely absent from nonpathogenic bacteria, are promising virulence blocker targets. The ability of mammalian cells to recognize the presence of a functional T3SS and trigger NF-κB activation provides a rapid and sensitive method for identifying chemical inhibitors of T3SS activity. In this study, we generated a HEK293 stable cell line expressing green fluorescent protein (GFP) driven by a promoter containing NF-κB enhancer elements to serve as a readout of T3SS function. We identified a family of synthetic cyclic peptide-peptoid hybrid molecules (peptomers) that exhibited dose-dependent inhibition of T3SS effector secretion in Yersinia pseudotuberculosis and Pseudomonas aeruginosa without affecting bacterial growth or motility. Among these inhibitors, EpD-3′N, EpD-1,2N, EpD-1,3′N, EpD-1,2,3′N, and EpD-1,2,4′N exhibited strong inhibitory effects on translocation of the Yersinia YopM effector protein into mammalian cells (>40% translocation inhibition at 7.5 μM) and showed no toxicity to mammalian cells at 240 μM. In addition, EpD-3′N and EpD-1,2,4′N reduced the rounding of HeLa cells caused by the activity of Yersinia effector proteins that target the actin cytoskeleton. In summary, we have discovered a family of novel cyclic peptomers that inhibit the injectisome T3SS but not the flagellar T3SS.


Bioorganic & Medicinal Chemistry | 2018

CycLS: Accurate, whole-library sequencing of cyclic peptides using tandem mass spectrometry

Chad E. Townsend; Akihiro Furukawa; Joshua Schwochert; Cameron R. Pye; Quinn Edmondson; R. Scott Lokey

Cyclic peptides are of great interest as therapeutic compounds due to their potential for specificity and intracellular activity, but specific compounds can be difficult to identify from large libraries without resorting to molecular encoding techniques. Large libraries of cyclic peptides are often DNA-encoded or linearized before sequencing, but both of those deconvolution strategies constrain the chemistry, assays, and quantification methods which can be used. We developed an automated sequencing program, CycLS, to identify cyclic peptides contained within large synthetic libraries. CycLS facilitates quick and easy identification of all library-members via tandem mass spectrometry data without requiring any specific chemical moieties or modifications within the library. Validation of CycLS against a library of 400 cyclic hexapeptide peptoid hybrids (peptomers) of unique mass yielded a result of 95% accuracy when compared against a simulated library size of 234,256 compounds. CycLS was also evaluated by resynthesizing pure compounds from a separate 1800-member library of cyclic hexapeptides and hexapeptomers with high mass redundancy. Of 22 peptides resynthesized, 17 recapitulated the retention times and fragmentation patterns assigned to them from the whole-library bulk assay results. Implementing a database-matching approach, CycLS is fast and provides a robust method for sequencing cyclic peptides that is particularly applicable to the deconvolution of synthetic libraries.


Archive | 2017

CHAPTER 13:Experimental and Computational Approaches to the Study of Macrocycle Conformations in Solution

Joshua Schwochert; R. Scott Lokey

Cyclic peptides have undergone a renaissance in medicinal chemistry, as studies into structure–property relationships have revealed that passive cell permeability can be designed into synthetic cyclic peptide scaffolds when conformational factors are considered. The elucidation of cyclic peptide conformations in low-dielectric, membrane-mimicking solvents such as chloroform has therefore become an important tool for studying passive permeability in cyclic peptides, while aqueous conformational ensembles correlate both to target engagement and aqueous solubility. This chapter reviews a variety of NMR and computational techniques for the study of cyclic peptide conformations in solution, with a focus on the use of coupling constants to obtain dihedral information, NOESY- and ROESY spectra to obtain through-space distances, and residual dipolar couplings to obtain the relative orientation of bond vectors. Hydrogen–deuterium exchange and temperature shift methods are also discussed as tools for evaluating hydrogen bonding, and computational methods that employ NMR-based restraints are compared.


Journal of Medicinal Chemistry | 2016

Passive Membrane Permeability in Cyclic Peptomer Scaffolds Is Robust to Extensive Variation in Side Chain Functionality and Backbone Geometry

Akihiro Furukawa; Chad E. Townsend; Joshua Schwochert; Cameron R. Pye; Maria A. Bednarek; R. Scott Lokey


Journal of Medicinal Chemistry | 2017

Nonclassical Size Dependence of Permeation Defines Bounds for Passive Adsorption of Large Drug Molecules

Cameron R. Pye; William M. Hewitt; Joshua Schwochert; Terra D. Haddad; Chad E. Townsend; Lyns Etienne; Yongtong Lao; Chris Limberakis; Akihiro Furukawa; Alan M. Mathiowetz; David A. Price; Spiros Liras; R. Scott Lokey

Collaboration


Dive into the Joshua Schwochert's collaboration.

Top Co-Authors

Avatar

R. Scott Lokey

University of California

View shared research outputs
Top Co-Authors

Avatar

Cameron R. Pye

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yongtong Lao

University of California

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge